Peripheral arterial disease primary prevention: Difference between revisions
| Line 15: | Line 15: | ||
|- | |- | ||
| colspan="1" style="text-align:center; background:LightGreen"|[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class I]] | | colspan="1" style="text-align:center; background:LightGreen"|[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class I]] | ||
'''1.'''Patients who are smokers or former smokers should be asked about status of tobacco use at every visit. ([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: A]]) | |- | ||
'''2.'''Patients should be assisted with counseling and developing a plan for quitting that may include pharmacotherapy and/or referral to a smoking cessation program. ([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: A]]) | | bgcolor="LightGreen"| '''1.'''Patients who are smokers or former smokers should be asked about status of tobacco use at every visit. ([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: A]]) | ||
'''3.'''Individuals with lower extremity PAD who smoke cigarettes or use other forms of tobacco should be advised by each of their clinicians to stop smoking and offered behavioral and pharmacological treatment. (([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: C]]) (changed from B to C) | |- | ||
'''4.'''In the absence of contraindication or other compelling clinical indication, 1 or more of the following pharmacological therapies should be offered: varenicline, bupropion, and nicotine replacement therapy. ([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: A]]) | | bgcolor="LightGreen"| '''2.'''Patients should be assisted with counseling and developing a plan for quitting that may include pharmacotherapy and/or referral to a smoking cessation program. ([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: A]]) | ||
|- | |||
| bgcolor="LightGreen"| '''3.'''Individuals with lower extremity PAD who smoke cigarettes or use other forms of tobacco should be advised by each of their clinicians to stop smoking and offered behavioral and pharmacological treatment. (([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: C]]) (changed from B to C) | |||
|- | |||
| bgcolor="LightGreen"| '''4.'''In the absence of contraindication or other compelling clinical indication, 1 or more of the following pharmacological therapies should be offered: varenicline, bupropion, and nicotine replacement therapy. ([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: A]]) | |||
|} | |||
==References== | ==References== | ||
Revision as of 18:39, 4 October 2012
|
Peripheral arterial disease Microchapters |
|
Differentiating Peripheral arterial disease from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
AHA/ACC Guidelines on Management of Lower Extremity PAD |
|
Guidelines for Structured Exercise Therapy for Lower Extremity PAD |
|
Guidelines for Minimizing Tissue Loss in Lower Extremity PAD |
|
Guidelines for Revascularization of Claudication in Lower Extremity PAD |
|
Guidelines for Management of Acute Limb Ischemial in Lower Extremity PAD |
|
Guidelines for Longitudinal Follow-up for Lower Extremity PAD |
|
Peripheral arterial disease primary prevention On the Web |
|
American Roentgen Ray Society Images of Peripheral arterial disease primary prevention |
|
Directions to Hospitals Treating Peripheral arterial disease |
|
Risk calculators and risk factors for Peripheral arterial disease primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Overview
Smoking Cessation
2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (Updating the 2005 Guideline) - Recommendations for Smoking Cessation (DO NOT EDIT)
| Class I |
| 1.Patients who are smokers or former smokers should be asked about status of tobacco use at every visit. (Level of Evidence: A) |
| 2.Patients should be assisted with counseling and developing a plan for quitting that may include pharmacotherapy and/or referral to a smoking cessation program. (Level of Evidence: A) |
| 3.Individuals with lower extremity PAD who smoke cigarettes or use other forms of tobacco should be advised by each of their clinicians to stop smoking and offered behavioral and pharmacological treatment. ((Level of Evidence: C) (changed from B to C) |
| 4.In the absence of contraindication or other compelling clinical indication, 1 or more of the following pharmacological therapies should be offered: varenicline, bupropion, and nicotine replacement therapy. (Level of Evidence: A) |